Bain Capital Life Sciences Fund, L.p. - Net Worth and Insider Trading

Bain Capital Life Sciences Fund, L.p. Net Worth

The estimated net worth of Bain Capital Life Sciences Fund, L.p. is at least $38 Million dollars as of 2024-11-13. Bain Capital Life Sciences Fund, L.p. is the 10% Owner of Annexon Inc and owns about 5,701,926 shares of Annexon Inc (ANNX) stock worth over $38 Million. Details can be seen in Bain Capital Life Sciences Fund, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bain Capital Life Sciences Fund, L.p. has not made any transactions after 2023-05-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Bain Capital Life Sciences Fund, L.p.

To

Bain Capital Life Sciences Fund, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bain Capital Life Sciences Fund, L.p. owns 7 companies in total, including Annexon Inc (ANNX) , Arcutis Biotherapeutics Inc (ARQT) , and Aptinyx Inc (APTX) among others .

Click here to see the complete history of Bain Capital Life Sciences Fund, L.p.’s form 4 insider trades.

Insider Ownership Summary of Bain Capital Life Sciences Fund, L.p.

Ticker Comapny Transaction Date Type of Owner
ANNX Annexon Inc 2023-05-25 10 percent owner
ARQT Arcutis Biotherapeutics Inc 2020-01-30 10 percent owner
APTX Aptinyx Inc 2020-01-14 10 percent owner
LIMIT LIMIT 2019-11-19 10 percent owner
LIMIT LIMIT 2018-07-19 10 percent owner
LIMIT LIMIT 2017-09-19 10 percent owner
LIMIT LIMIT 2021-07-14 10 percent owner

Bain Capital Life Sciences Fund, L.p. Latest Holdings Summary

Bain Capital Life Sciences Fund, L.p. currently owns a total of 1 stock. Bain Capital Life Sciences Fund, L.p. owns 5,701,926 shares of Annexon Inc (ANNX) as of May 25, 2023, with a value of $38 Million.

Latest Holdings of Bain Capital Life Sciences Fund, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ANNX Annexon Inc 2023-05-25 5,701,926 6.62 37,746,750

Holding Weightings of Bain Capital Life Sciences Fund, L.p.


Bain Capital Life Sciences Fund, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Bain Capital Life Sciences Fund, L.p. has made a total of 2 transactions in Annexon Inc (ANNX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Annexon Inc is the acquisition of 300,000 shares on May 25, 2023, which cost Bain Capital Life Sciences Fund, L.p. around $639,000.

Insider Trading History of Bain Capital Life Sciences Fund, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bain Capital Life Sciences Fund, L.p. Trading Performance

GuruFocus tracks the stock performance after each of Bain Capital Life Sciences Fund, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bain Capital Life Sciences Fund, L.p. is 32.52%. GuruFocus also compares Bain Capital Life Sciences Fund, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Bain Capital Life Sciences Fund, L.p. within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Bain Capital Life Sciences Fund, L.p.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Bain Capital Life Sciences Fund, L.p.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 50.31 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 43.44 LIMIT LIMIT LIMIT LIMIT LIMIT

Bain Capital Life Sciences Fund, L.p. Ownership Network

Ownership Network List of Bain Capital Life Sciences Fund, L.p.

No Data

Ownership Network Relation of Bain Capital Life Sciences Fund, L.p.

Insider Network Chart

Bain Capital Life Sciences Fund, L.p. Owned Company Details

What does Annexon Inc do?

Who are the key executives at Annexon Inc?

Bain Capital Life Sciences Fund, L.p. is the 10 percent owner of Annexon Inc. Other key executives at Annexon Inc include EVP & Chief Innovation Officer Ted Yednock , EVP & Chief Business Officer Michael Overdorf , and EVP & Chief Financial Officer Jennifer Lew .

Annexon Inc (ANNX) Insider Trades Summary

Over the past 18 months, Bain Capital Life Sciences Fund, L.p. made 1 insider transaction in Annexon Inc (ANNX) with a net purchase of 300,000. Other recent insider transactions involving Annexon Inc (ANNX) include a net sale of 74,985 shares made by Ted Yednock , a net purchase of 22,400 shares made by William H. Carson , and a net sale of 6,563 shares made by Jennifer Lew .

In summary, during the past 3 months, insiders sold 26,408 shares of Annexon Inc (ANNX) in total and bought 6,400 shares, with a net sale of 20,008 shares. During the past 18 months, 92,392 shares of Annexon Inc (ANNX) were sold and 672,400 shares were bought by its insiders, resulting in a net purchase of 580,008 shares.

Annexon Inc (ANNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Annexon Inc Insider Transactions

No Available Data

Bain Capital Life Sciences Fund, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Bain Capital Life Sciences Fund, L.p.. You might contact Bain Capital Life Sciences Fund, L.p. via mailing address: 200 Clarendon Street, Boston Ma 02116.